Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tevogen Inc. - Common Stock (NQ:TVGN)

6.820 +0.200 (+3.02%)
Delayed Quote Updated: 1:02 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,927
Open 6.350
Bid (Size) 6.350 (300)
Ask (Size) 7.170 (400)
Prev. Close 6.620
Today's Range 6.350 - 6.985
52wk Range 3.636 - 40.45
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
Both previously disclosed Nasdaq compliance matters are now closed 
From Tevogen Inc.
Via GlobeNewswire
News headline image
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
From Tevogen Bio Inc
Via GlobeNewswire

Performance

YTD
-62.5%
-62.5%
1 Month
-2.3%
-2.3%
3 Month
+18.8%
+18.8%
6 Month
+52.2%
+52.2%
1 Year
-82.6%
-82.6%

More News

Read More
News headline image
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Announces Formation of a Healthcare Services Initiative
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Letter to Shareholders from CEO Dr. Ryan Saadi
From Tevogen Bio Inc
Via GlobeNewswire
What's going on in today's session ↗
Via Chartmill
News headline image
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
From Tevogen Bio Inc
Via GlobeNewswire
What's going on in today's pre-market session ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
Topics Stocks
News headline image
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Says ‘Actively Evaluating’ Potential Acquisitions ↗
Via Stocktwits
News headline image
Letter to Shareholders from CEO Dr. Ryan Saadi
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Shares Take Further Beating On Gauging Deal With Apozel Pharmaceuticals ↗
Via Stocktwits
News headline image
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
From Tevogen Bio Inc
Via GlobeNewswire
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill

Frequently Asked Questions

Is Tevogen Inc. - Common Stock publicly traded?
Yes, Tevogen Inc. - Common Stock is publicly traded.
What exchange does Tevogen Inc. - Common Stock trade on?
Tevogen Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tevogen Inc. - Common Stock?
The ticker symbol for Tevogen Inc. - Common Stock is TVGN on the Nasdaq Stock Market
What is the current price of Tevogen Inc. - Common Stock?
The current price of Tevogen Inc. - Common Stock is 6.820
When was Tevogen Inc. - Common Stock last traded?
The last trade of Tevogen Inc. - Common Stock was at 10/01/26 01:02 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.